ACET |
Adicet Bio, Inc. |
Aug 14, 2023 |
10 |
0 |
4 |
Aug 16, 2023 |
Director |
ACET |
Adicet Bio, Inc. |
Jun 1, 2023 |
2 |
0 |
4 |
Jun 2, 2023 |
Director |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
May 5, 2023 |
2 |
-1,145,213 |
4 |
May 9, 2023 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
May 2, 2023 |
5 |
-1,544,187 |
4 |
May 4, 2023 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Apr 12, 2023 |
3 |
-2,472,164 |
4 |
Apr 14, 2023 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Apr 4, 2023 |
5 |
-164,854 |
4 |
Apr 6, 2023 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Mar 31, 2023 |
1 |
-459,943 |
4 |
Apr 4, 2023 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Mar 16, 2023 |
2 |
-825,423 |
4 |
Mar 20, 2023 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Feb 24, 2023 |
1 |
-1,147,806 |
4 |
Feb 28, 2023 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Feb 17, 2023 |
1 |
-1,098,188 |
4 |
Feb 22, 2023 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Feb 14, 2023 |
2 |
-655,161 |
4 |
Feb 16, 2023 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Feb 10, 2023 |
3 |
-1,593,878 |
4 |
Feb 14, 2023 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Feb 1, 2023 |
3 |
0 |
4 |
Feb 3, 2023 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Jan 31, 2023 |
1 |
-34,450 |
4 |
Feb 2, 2023 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Nov 1, 2022 |
8 |
-340,306 |
4 |
Nov 3, 2022 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Oct 18, 2022 |
2 |
-537,860 |
4 |
Oct 20, 2022 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Aug 1, 2022 |
1 |
-211,891 |
4 |
Aug 3, 2022 |
EVP, Cell & Genetic Therapies |
ACET |
Adicet Bio, Inc. |
Jun 2, 2022 |
1 |
0 |
4 |
Jun 3, 2022 |
Director |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
May 16, 2022 |
5 |
-11,377 |
4 |
May 18, 2022 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
May 4, 2022 |
1 |
-9,903 |
4 |
May 6, 2022 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
May 2, 2022 |
7 |
-82,930 |
4 |
May 4, 2022 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Apr 29, 2022 |
1 |
-211,546 |
4 |
May 3, 2022 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Apr 7, 2022 |
3 |
-154,935 |
4 |
Apr 8, 2022 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Apr 4, 2022 |
3 |
-1,021,005 |
4 |
Apr 6, 2022 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Apr 1, 2022 |
1 |
-353,593 |
4 |
Apr 5, 2022 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Mar 17, 2022 |
1 |
-530,627 |
4 |
Mar 21, 2022 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Feb 17, 2022 |
1 |
-799,602 |
4 |
Feb 22, 2022 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Feb 10, 2022 |
1 |
-232,747 |
4 |
Feb 14, 2022 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Feb 1, 2022 |
8 |
-389,172 |
4 |
Feb 3, 2022 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Nov 1, 2021 |
1 |
-141,764 |
4 |
Nov 3, 2021 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
Jul 30, 2021 |
1 |
-153,499 |
4 |
Aug 3, 2021 |
EVP, Cell & Genetic Therapies |
VRTX |
VERTEX PHARMACEUTICALS INC / MA |
May 17, 2021 |
2 |
-24,230 |
4 |
May 19, 2021 |
EVP, Cell & Genetic Therapies |